| Prev Close: | 6.19 |
|---|---|
| Open: | 6.07 |
| Bid: | 6.25 x 700 |
| Ask: | 6.26 x 1500 |
| 1y Target Est: | 10.57 |
| Beta: | 2.69 |
| Next Earnings Date: | 7-Aug-13 |
| Day's Range: | 6.02 - 6.47 |
|---|---|
| 52wk Range: | 3.10 - 7.73 |
| Volume: | 784,222 |
| Avg Vol (3m): | 1,116,800 |
| Market Cap: | 593.41M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.29 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Pipeline Obesity Treatments You Should Watchat Motley Fool(Wed May 22)
- Orexigen Therapeutics' CEO Presents at 2013 UBS Global Healthcare Services Conference (Transcript)at Seeking Alpha(Wed May 22)
- The 9 Most Obese Countries in the Worldat Motley Fool(Mon May 20)
- Orexigen Therapeutics to Present at the UBS Global Healthcare ConferencePR Newswire(Fri May 17)
- Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager Finny Kuruvilla Discusses His Portfolio Construction Strategy with The Wall Street TranscriptWall Street Transcript(Thu May 16)
- Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference - Transcriptat Seeking Alpha(Wed May 15)
- Weight Loss Isn't Just for Looking Good Anymoreat Motley Fool(Wed May 15)
- OREXIGEN THERAPEUTICS, INC. FinancialsEDGAR Online Financials(Wed May 15)
- Will Obesity Drugs Gain Soon?at Motley Fool(Wed May 15)
- Looking at Arena Following Sell-Offat Motley Fool(Tue May 14)
- Vivus Starting To Gain The Advantage Over Arenaat Seeking Alpha(Tue May 14)
- SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.Business Wire(Mon May 13)
- Why Does Arena's Obesity Drug Have Abuse Potential?at Forbes(Sat May 11)
- Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Fri May 10)
- ARNA Sheds Light on Belviq LaunchZacks(Thu May 9)
Press Releases
- MDT, HLF, OREX, and NVS Early Briefing and ReviewAccesswire(Mon May 6)
- Equities Review and Reports For (NYSE: RDN) (NASDAQ: OREX)Accesswire(Fri Apr 26)
- Trader’s Favourite Stocks: Amazon.com, Microsoft Corporation, Orexigen Therapeutics, Nokia CorporationAccesswire(Thu Sep 6)
Must Read
- US new home sales rise 2.3 per cent in April while median home prices hit record highThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- The Galapagos are now just a click away: Google photographs famous islands for Street ViewThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- TD Bank second-quarter rises but comes in short of consensus estimatesThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- US stock prices ease, recovering most of an early swoon, after Chinese manufacturing contractsThe Canadian Press(1969-12-31T18:59:59GMT-05:00)